3 results about "Gastritis chronic" patented technology

This invention discloses a Zhishu Yangwei tablet for chronic gastritis and its granule dry-compression tableting process, relating to the field of traditional Chinese medicine preparation technology. The Yangwei tablet is made from the following raw materials in parts by weight: Codonopsis pilosula 35-45 parts, stir-fried Atractylodes macrocephala 18-22 parts, Poria cocos 18-22 parts, Glycyrrhiza uralensis 8-12 parts, Amomum villosum 18-22 parts, Lindera strychnifolia 18-22 parts, Salvia miltiorrhiza 45-55 parts, roasted Aucklandia lappa 18-22 parts, Paeonia lactiflora 18-22 parts, stir-fried Citrus aurantium 18-22 parts, Magnolia officinalis 28-32 parts, Lilium brownii 35-45 parts, and stir-fried chicken gizzard lining 18- 22 parts, dried plum 45-55 parts, Coptis chinensis 8-12 parts, hawthorn 35-45 parts, magnesium stearate 5-7 parts, sucrose 28-32 parts; This invention uses low-temperature dynamic extraction technology to replace the traditional high-temperature decoction process, effectively reducing the decomposition loss of heat-sensitive active ingredients such as tanshinone IIA and ursolic acid, and improving the bioavailability of the drug. It also uses membrane concentration and spray drying technology to replace the traditional atmospheric pressure concentration and oven drying process, shortening the production cycle, reducing energy consumption, and avoiding the degradation of active ingredients caused by prolonged heating of materials.

The present application relates to the field of traditional Chinese medicine, and particularly to a composition for treating chronic gastritis and application thereof, the composition is prepared from the following raw materials according to weight fraction: 8-12 parts of Fashanxia, 8-12 parts of Huangqin, 3-7 parts of Huanglian, 4-8 parts of Ganjiang, 12-18 parts of Taizishen, 12-18 parts of Baihuasheshecao, 12-16 parts of Banzhilian, 8-12 parts of E'zhu, 12-20 parts of Chaozhigu, 18-22 parts of Chaoquya, 18-22 parts of Chaomaiya, 8-12 parts of Yujin, 1-5 parts of Sanqi, 8-12 parts of Dazao and 3-8 parts of Zhigancao. The present application effectively solves the problems of lack of specific therapy and specific intervention target for reversing mucosal atrophy, intestinal metaplasia and other precancerous lesions in the prior art, provides a new idea for the mechanism research of CAG treatment by traditional Chinese medicine, and has important theoretical value and clinical conversion prospect for promoting the modernization of traditional Chinese medicine.

The present application relates to the field of traditional Chinese medicine, and provides a traditional Chinese medicine composition for treating chronic gastritis with cold and heat symptoms, which is prepared from the following traditional Chinese medicines in parts by weight: 20-45 parts of lily, 10-25 parts of Jiang Banxia, 10-25 parts of atractylodes, 10-25 parts of white peony root, 8-20 parts of codonopsis, 8-20 parts of Anemarrhena, 8-20 parts of areca nut, 8-20 parts of magnolia bark, 8-20 parts of jujube, 6-15 parts of scutellaria, 6-15 parts of dried ginger, 6-15 parts of licorice, 6-15 parts of fried licorice, 3-12 parts of sandalwood, and 1.5-6 parts of coptis. The present application is based on the theory of traditional Chinese medicine, and can regulate the whole body through multiple targets such as clearing heat and dampness, harmonizing stomach and descending adverse qi, promoting qi circulation and eliminating mass, and nourishing yin and strengthening the body resistance. The present application can promote blood circulation and qi circulation, unblock qi, and improve the overall health of patients with chronic gastritis. Moreover, the present application has few side effects and is suitable for long-term use.